Heme oxygenase (HO-1) is involved in the negative regulation of contact sensitivity reaction

Pharmacological Reports

Volumn 60, Issue 6, 2008, Pages 933-940

  Majewska, Monika ^a   Zaja̧c, Katarzyna ^a   Dulak, Jósef ^b   Szczepanik, Marian ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Contact sensitivity; Heme oxygenase; Inflammation; Tregulatory cells

Indexed keywords

HEME; HEME OXYGENASE 1; PROTOPORPHYRIN TIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRINITROPHENYL; HMOX1 PROTEIN, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; NITROBENZENE DERIVATIVE; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CBA MOUSE; CELL ISOLATION; CONTACT SENSITIVITY; CONTROLLED STUDY; DBA 1 MOUSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOREGULATION; LYMPH NODE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SHAM PROCEDURE; SPLEEN CELL; SWISS JAMES LAMBERT MOUSE; ANIMAL; CONTACT DERMATITIS; DBA MOUSE; IMMUNOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; DERMATITIS, CONTACT; HEME; HEME OXYGENASE-1; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED CBA; MICE, INBRED DBA; PROTOPORPHYRINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TRINITROBENZENES;

EID: 65249180706     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abraham NG, Kappas A: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev, 2008, 60, 79-127.
2. Abraham NG, Tsenovoy PL, McClung J, Drummond GS: Heme oxygenase: a target gene for anti-diabetic and obesity. Curr Pharm Des, 2008, 14, 412-421.
3. Agarwal A, Nick HS: Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol, 2000, 11, 965-973.
4. Alcaraz MJ, Habib A, Créminon C, Vicente AM, Lebert M, Lévy-Toledano S, Maclouf J: Heme oxygenase-1 induction by nitric oxide in raw 264.7 macrophages is upregulated by a cyclo-oxygenase-2 inhibitor. Biochim Biophys Acta, 2001, 1526, 13-16.
5. Askenase PW: Effector and regulatory molecules and mechanisms in delayed hypersensitivity. In: Allergy: Principles and Practice, 5th edn. Ed. Adkinson NF Jr., Mosby Co, St. Louis, 1998, 323-341.
6. Askenase PW, Szczepanik M, Itakura A, Kiener C, Campos R A: Extravascular T-cell recruitment requires initiation begun by Vα14+ invariant NK T cells and B-1 cells. Trends Immunol, 2004, 25, 441-449.
7. Bednarz N, Zawacka-Pankau J, Kowalska A: Protoporphyrin IX induces apoptosis in HeLa cells prior to photodynamic treatment. Pharmacol Rep, 2007, 59, 474-479.
8. Botros FT, Schwartzman ML, Stier CT Jr., Goodman AI, Abraham NG: Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int, 2005, 68, 2745-2755.
9. Campos R, Szczepanik M, Itakura A, Akahira-Azuma M, Sidobre S, Kronenberg M, Askenase PW: Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med, 2003, 198, 1785-1796.
10. Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, Lee LY et al.: Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest, 2007, 117, 438-447.
11. Diepgen TL, Weisshaar E: Contact dermatitis: epidemiology and frequent sensitizers to cosmetics. J Eur Acad Dermatol Venereol, 2007, 21, 9-13.
12. Durante W, Christodoulides N, Cheng K, Peyton KJ, Sunahara RK, Schafer AI: cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Am J Physiol, 1977, 273, 317-323.
13. El Andaloussi A, Lesniak MS: CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J Neurooncol, 2007, 83, 145-152.
14. Florczyk UM, Józkowicz A, Dulak J: Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance. Pharmacol Rep, 2008, 60, 38-48.
15. Fyhrquist-Vanni N, Alenius H, Lauerma A: Contact dermatitis. Dermatol Clin, 2007, 25, 613-623.
16. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M: Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene, 2004, 336, 241-250.
17. Li M, Kim DH, Tsenovoy P, Peterson SJ, Rezzani R, Rodella LF, Aronow WS et al.: Treatment of obese diabetic mice with an heme oxygenase inducer reduces visceral and abdominal adiposity increases adiponectin levels and improves insulin sensitibility and glucose tolerance. Diabetes, 2008, 57, 1526-1535.
18. Listopad J, Asadullah K, Sievers C, Ritter T, Meisel C, Sabat R, Docke W-D: Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol, 2007, 16, 661-670.
19. Maines MD: The heme oxygenase system: a regulator of second messenger genes. Annu Rev Pharmacol Toxicol, 1997, 37, 517-554.
20. Majewska M, Zajac K, Kubera M, Bryniarski K, Ptak M, Basta-Kaim A, Ksiazek L et al.: Effects of ovalbumin on survival of H-Y incompatible skin graft In C57Bl/6 mice. Pharmacol Rep, 2006, 58, 439-442.
21. Majewska M, Zajac K, Srebro Z, Sura P, Ksiazek L, Zemelka M, Szczepanik M: Epicutaneous immunization with myelin basic protein protects from the experimental autoimmune encephalomyelitis. Pharmacol Rep, 2007, 59, 74-79.
22. Masini E, Vannacci A, Marzocca C, Pierpaoli S, Giannini L, Fantappie O, Mazzanti R, Mannaioni PF: Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp Biol Med, 2003, 228, 546-549.
23. McCoubrey WK Jr, Huang TJ, Maines MD: Isolation and characterization of cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem, 1997, 247, 725-732.
24. Oliveira V, Agua-Doce A, Duarte J, Soares MP, Graca L: Regulatory T cell maintenance of dominant tolerance: Induction of tissue self-defense. Transplant Immunol, 2006, 17, 7-10.
25. Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol, 2003, 24, 449-455.
26. Ptak W, Szczepanik M, Ramabhadran R, Askenase PW: Immune or normal γδ T cells that asssist αβ T cells in elicitation of contact sensitivity preferentially use Vγ5 and Vδ4 variable region gene segments. J Immunol, 1996, 156, 976-986.
27. Soares MP, Bach FH: Heme oxygenase-1 in organ transplantation. Front Biosci, 2007, 1, 4932-4945.
28. Suttervala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberg SG, Bertin G J, Coyle AJ et al.: Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity, 2006, 24, 317-327.
29. Szczepanik M: Skin-induced tolerance and its reversal by Toll-like receptor ligands. Arch Immunol Ther Exp, 2007, 55, 161-172.
30. Szczepanik M, Anderson LR, Ushio H, Ptak W, Owen M., Hayday AC, Askenase PW: γδ T cells from tolerized αβ T cell receptor (TCR)-deficient mice inhibit contact sensitivity-effector T cells in vivo, and their interferon-γ production in vitro. J Exp Med, 1996, 184, 2129-2139.
31. Szczepanik M, Bryniarski K, Tutaj M, Ptak M, Skrzeczyńska J, Askenase PW, Ptak W: Epicutaneous immunization induces αβ T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-γ. Immunology, 2005, 115, 42-54.
32. Szczepanik M, Lewis J, Geba GP, Ptak W, Askenase PW: Positive regulatory γδ T cells in contact sensitivity: augmented responses by in vivo treatment with anti-γδ monoclonal antibody, or anti-Vγ5 or Vδ4. Immunol Invest, 1998, 27, 1-15.
33. Thysen JP, Johansen JD, Menne T: Contact allergy epidemics and their controls. Contact Dermatit, 2007, 56, 185-195.
34. Tsuji RF, Szczepanik M, Kavikowa I, Paliwal V, Campos RA, Itakura A, Akahira-Azuma M et al.: B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med, 2002, 196, 1277-1290.
35. Xia ZW, Xu LQ, Zhong WW, Wei JJ, Li NL, Shao J, Li YZ et al.: Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-1. Am J Pathol, 2007, 171, 1904-1914.
36. Xia ZW, Zhong WW, Xu LQ, Sun JL, Shen OX, Wang JG, Shao J et al.: Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol, 2006, 177, 5936-5945.